Evidence vs adoption in PKU monitoring: Understanding the implementation gap

--Date of event: 04/15/2026 Speaker: -Rachel Carling Director, Biochemical Sciences, Synnovis -Neil Spooner Director Spooner Bioanalytical Solutions & Chair Patient Centric Sampling Interest Group Intended audience: Of interest to scientists, clinicians, dietitians, patient representatives. What you will learn: -Background to monitoring DBS phenylalanine and tyrosine in patients with phenylketonuria. -The pre-analytical and analytical challenges associated with the current lab tests. -Evidence-based solutions to these challenges. -The patient perspective. -The conundrum of clinical implementation. Chapters: -00:00 – 07:22 | PKU Basics & Why Monitoring Matters -05:33 – 14:30 | Current Workflow & Analytical Limitations -14:31 – 33:42 | Sample Quality Issues & Emerging Solutions -33:43 – 56:03 | The Implementation Gap & Path Forward About the PCSIG: The PCSIG is a not-for-profit organization that brings together a variety of interested parties who wish to develop and promote the use of patient centric sampling technologies for blood, plasma and other human matrices to better facilitate the advancement of human healthcare and well-being. Learn more by visiting www.pcsig.org